
Repro Med Systems KRMD
€ 4.01
0.64%
Quartalsbericht 2025-Q3
hinzugefügt 12.11.2025
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NASDAQ CAPITAL |
Anteile |
45.6 M |
Marktkapitalisierung |
$ 215 M |
EBITDA (LTM) |
$ -3.27 M |
P/E (LTM) |
235.0 |
P/S (LTM) |
5.58 |
EPS (LTM) |
0.02 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 184.86 | 1.31 % | $ 53.2 B | NYSE,SPB | ||
|
Baxter International
BAX
|
$ 21.74 | 1.85 % | $ 11.2 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Ekso Bionics Holdings
EKSO
|
$ 11.29 | -8.21 % | $ 228 M | Nasdaq Capital Market | ||
|
ICU Medical
ICUI
|
$ 155.85 | 4.08 % | $ 3.84 B | Nasdaq Global Select Market,SPB | ||
|
Alcon
ALC
|
$ 82.21 | -1.21 % | $ 40.4 B | NYSE | ||
|
AtriCure
ATRC
|
$ 32.79 | 1.27 % | $ 1.57 B | Nasdaq Global Market,SPB | ||
|
electroCore
ECOR
|
$ 6.16 | -0.16 % | $ 34 K | Nasdaq Global Select Market | ||
|
Harvard Bioscience
HBIO
|
$ 0.58 | -0.56 % | $ 24.6 M | Nasdaq Global Market | ||
|
LeMaitre Vascular
LMAT
|
$ 92.55 | 0.75 % | $ 2.08 B | Nasdaq Global Market,SPB | ||
|
AngioDynamics
ANGO
|
$ 11.22 | 0.13 % | $ 458 M | Nasdaq Global Select Market | ||
|
InfuSystem Holdings
INFU
|
$ 7.9 | - | $ 163 M | NYSE American | ||
|
The Cooper Companies
COO
|
$ 84.11 | 0.51 % | $ 16.7 B | NYSE,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 61.61 | 1.55 % | $ 3.1 B | NYSE,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 150.56 | -5.24 % | $ 4.82 B | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Glaukos Corporation
GKOS
|
$ 119.69 | 2.21 % | $ 5.8 B | NYSE,SPB | ||
|
OraSure Technologies
OSUR
|
$ 2.76 | -2.47 % | $ 205 M | Nasdaq Global Select Market,SPB | ||
|
Masimo Corporation
MASI
|
$ 175.38 | 0.03 % | $ 9.35 B | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 504.2 | 0.93 % | $ 180 B | Nasdaq Global Select Market,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 82.25 | 0.5 % | $ 4.79 B | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.07 | -3.95 % | $ 21.1 M | Nasdaq Global Select Market | ||
|
Nephros
NEPH
|
$ 4.14 | 6.43 % | $ 43 M | Nasdaq Global Select Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.26 | -2.04 % | $ 20.7 M | NYSE American | ||
|
DENTSPLY SIRONA
XRAY
|
$ 12.63 | 0.88 % | $ 2.57 B | Nasdaq Global Select Market,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 29.16 | 1.53 % | $ 4.9 B | NYSE | ||
|
Pro-Dex
PDEX
|
$ 39.55 | 1.41 % | $ 130 M | Nasdaq Global Select Market | ||
|
Pulse Biosciences
PLSE
|
$ 21.98 | -12.38 % | $ 1.48 B | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
Stereotaxis
STXS
|
$ 2.08 | -0.24 % | $ 168 M | NYSE American | ||
|
Repligen Corporation
RGEN
|
$ 136.76 | -0.34 % | $ 7.62 M | Nasdaq Global Select Market,SPB | ||
|
ResMed
RMD
|
$ 258.04 | 0.68 % | $ 37.7 B | NYSE,SPB | ||
|
BioLife Solutions
BLFS
|
$ 23.17 | -0.26 % | $ 1.07 B | Nasdaq Global Select Market | ||
|
STERIS plc
STE
|
$ 250.32 | -0.34 % | $ 24.7 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.67 | -3.48 % | $ 20.1 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 17.65 | -1.29 % | $ 867 M | Nasdaq Global Market,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 115.88 | 3.65 % | $ 5.43 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 67.96 | 2.09 % | $ 247 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 241.54 | -0.94 % | $ 17.5 B | NYSE,SPB |